Trial
NCT04220892
Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
Early Phase IWITHDRAWNSAFETYConfidence: HIGH
Sponsor
Jose Carrillo
Collaborators
Eli Lilly and Company
Condition
High Grade Glioma
Intervention
Pembrolizumab
Why stopped
One of the study drugs will no longer be supplied by manufacturer and the pembrolizumab + abemaciclib study arm is removed due to toxicity seen in other trials.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-31